214 related articles for article (PubMed ID: 35922860)
1. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set.
Conway Morris A; Kohler K; De Corte T; Ercole A; De Grooth HJ; Elbers PWG; Povoa P; Morais R; Koulenti D; Jog S; Nielsen N; Jubb A; Cecconi M; De Waele J;
Crit Care; 2022 Aug; 26(1):236. PubMed ID: 35922860
[TBL] [Abstract][Full Text] [Related]
2. Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study.
Pandey M; May A; Tan L; Hughes H; Jones JP; Harrison W; Bradburn S; Tyrrel S; Muthuswamy B; Berry N; Pugh R; Sutton D; Campbell A; Morgan M
Crit Care; 2022 Jun; 26(1):158. PubMed ID: 35655224
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and risk factors associated with secondary bacterial pneumonia among COVID-19 patients in ICU.
Ekiz Iscanli IG; Aydin M; Şaylan B
J Infect Dev Ctries; 2023 Oct; 17(10):1387-1393. PubMed ID: 37956367
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.
Moreno G; Rodríguez A; Reyes LF; Gomez J; Sole-Violan J; Díaz E; Bodí M; Trefler S; Guardiola J; Yébenes JC; Soriano A; Garnacho-Montero J; Socias L; Del Valle Ortíz M; Correig E; Marín-Corral J; Vallverdú-Vidal M; Restrepo MI; Torres A; Martín-Loeches I;
Intensive Care Med; 2018 Sep; 44(9):1470-1482. PubMed ID: 30074052
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Secondary infections in critically ill patients with viral pneumonia due to COVID-19 and influenza: a historical cohort study.
Beliavsky A; Johnston B; Li Q; Tomlinson G; Kaul R; Granton J
Can J Anaesth; 2023 Mar; 70(3):374-383. PubMed ID: 36918454
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital's Five-Month Experience.
Posteraro B; Cortazzo V; Liotti FM; Menchinelli G; Ippoliti C; De Angelis G; La Sorda M; Capalbo G; Vargas J; Antonelli M; Sanguinetti M; De Pascale G; Spanu T
Microbiol Spectr; 2021 Dec; 9(3):e0069521. PubMed ID: 34756067
[TBL] [Abstract][Full Text] [Related]
8. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.
Baskaran V; Lawrence H; Lansbury LE; Webb K; Safavi S; Zainuddin NI; Huq T; Eggleston C; Ellis J; Thakker C; Charles B; Boyd S; Williams T; Phillips C; Redmore E; Platt S; Hamilton E; Barr A; Venyo L; Wilson P; Bewick T; Daniel P; Dark P; Jeans AR; McCanny J; Edgeworth JD; Llewelyn MJ; Schmid ML; McKeever TM; Beed M; Lim WS
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861190
[No Abstract] [Full Text] [Related]
9. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study.
Fierens J; De Bus L; Colpaert K; Boelens J; Gadeyne B; Decruyenaere J; Van Braeckel E; Depuydt P
Acta Clin Belg; 2022 Oct; 77(5):837-844. PubMed ID: 34709997
[TBL] [Abstract][Full Text] [Related]
11. What happened during COVID-19 in African ICUs? An observational study of pulmonary co-infections, superinfections, and mortality in Morocco.
Aissaoui Y; Ennassimi Y; Myatt I; El Bouhiaoui M; Nabil M; Bahi M; Arsalane L; Miloudi M; Belhadj A
PLoS One; 2022; 17(12):e0278175. PubMed ID: 36454978
[TBL] [Abstract][Full Text] [Related]
12. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation.
De Bruyn A; Verellen S; Bruckers L; Geebelen L; Callebaut I; De Pauw I; Stessel B; Dubois J
BMC Infect Dis; 2022 Mar; 22(1):207. PubMed ID: 35236299
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
[TBL] [Abstract][Full Text] [Related]
14. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
Torres A; Motos A; Cillóniz C; Ceccato A; Fernández-Barat L; Gabarrús A; Bermejo-Martin J; Ferrer R; Riera J; Pérez-Arnal R; García-Gasulla D; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Almansa R; Menéndez R; Palomeque A; Villar RA; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Boado MV; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego E; García Garmendia JL; Gómez JM; Huerta A; García RNJ; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; López Messa J; Albaiceta GM; Nieto M; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Serra-Fortuny M; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Barbé F;
Intensive Care Med; 2022 Jul; 48(7):850-864. PubMed ID: 35727348
[TBL] [Abstract][Full Text] [Related]
15. A Multicenter, Prospective, Observational Study to Determine Predictive Factors for Multidrug-Resistant Pneumonia in Critically Ill Adults: The DEFINE Study.
Lat I; Daley MJ; Shewale A; Pangrazzi MH; Hammond D; Olsen KM;
Pharmacotherapy; 2019 Mar; 39(3):253-260. PubMed ID: 30101412
[TBL] [Abstract][Full Text] [Related]
16. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
[TBL] [Abstract][Full Text] [Related]
17. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
[TBL] [Abstract][Full Text] [Related]
18. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
[TBL] [Abstract][Full Text] [Related]
19. Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
Chen Z; Zhan Q; Huang L; Wang C
Front Public Health; 2023; 11():1195048. PubMed ID: 37711242
[TBL] [Abstract][Full Text] [Related]
20. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
